PDS Biotechnology PDSB
NASDAQ PDSB
$1.24 +0.28 (+29.10%)
At close: Oct 21, 2026 · 4:00 PM EDT

PDS Biotechnology (PDSB) Other Non-Current Liabilities (2014 - 2018)

Updated

PDS Biotechnology's Other Non-Current Liabilities was $291,225 in Q4 2018.

Analysis

PDS Biotechnology (PDSB) Other Non-Current Liabilities (2014 - 2018) Analysis & Trends

  • Other Non-Current Liabilities shows a four-year compound annual growth rate of -35.4% (FY2014 to FY2018).
  • In earlier years, Other Non-Current Liabilities was $1.67 million in FY2014.
  • The Q4 2018 figure marks the highest quarterly Other Non-Current Liabilities since Q3 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 PDS Biotechnology 69.30 Mn -21.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 291,225.00
Sep 30, 2015 3.73 Mn
Dec 31, 2014 1.67 Mn
API Access

PDS Biotechnology Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PDSB&period=max&api_key=YOUR_API_KEY